NO994178D0 - Atropisomere av 3-heteroaryl-4(3H)-kinazoloner for behandling av neurodegenerative og CNS-trauma-relaterte tilstander - Google Patents

Atropisomere av 3-heteroaryl-4(3H)-kinazoloner for behandling av neurodegenerative og CNS-trauma-relaterte tilstander

Info

Publication number
NO994178D0
NO994178D0 NO994178A NO994178A NO994178D0 NO 994178 D0 NO994178 D0 NO 994178D0 NO 994178 A NO994178 A NO 994178A NO 994178 A NO994178 A NO 994178A NO 994178 D0 NO994178 D0 NO 994178D0
Authority
NO
Norway
Prior art keywords
quinazolones
atropisomers
neurodegenerative
heteroaryl
treatment
Prior art date
Application number
NO994178A
Other languages
English (en)
Other versions
NO994178L (no
Inventor
Bertrand Leo Chenard
Keith Michael Devries
Jr Willard Mckowan Welch
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO994178L publication Critical patent/NO994178L/no
Publication of NO994178D0 publication Critical patent/NO994178D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
NO994178A 1997-02-28 1999-08-27 Atropisomere av 3-heteroaryl-4(3H)-kinazoloner for behandling av neurodegenerative og CNS-trauma-relaterte tilstander NO994178D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3854097P 1997-02-28 1997-02-28
PCT/IB1998/000151 WO1998038187A1 (en) 1997-02-28 1998-02-06 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions

Publications (2)

Publication Number Publication Date
NO994178L NO994178L (no) 1999-08-27
NO994178D0 true NO994178D0 (no) 1999-08-27

Family

ID=21900535

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994178A NO994178D0 (no) 1997-02-28 1999-08-27 Atropisomere av 3-heteroaryl-4(3H)-kinazoloner for behandling av neurodegenerative og CNS-trauma-relaterte tilstander

Country Status (40)

Country Link
US (1) US6380204B1 (no)
EP (1) EP0964860B1 (no)
JP (1) JP3299990B2 (no)
KR (1) KR20000075812A (no)
CN (1) CN1248254A (no)
AP (1) AP9801202A0 (no)
AR (1) AR011886A1 (no)
AT (1) ATE264854T1 (no)
AU (1) AU732448B2 (no)
BG (1) BG103687A (no)
BR (1) BR9807807A (no)
CA (1) CA2282279C (no)
CO (1) CO4950615A1 (no)
DE (1) DE69823339T2 (no)
DK (1) DK0964860T3 (no)
DZ (1) DZ2438A1 (no)
EA (1) EA001961B1 (no)
ES (1) ES2218801T3 (no)
GT (1) GT199800039A (no)
HN (1) HN1998000028A (no)
HR (1) HRP980108B1 (no)
HU (1) HUP0000935A3 (no)
ID (1) ID23435A (no)
IL (1) IL130897A0 (no)
IS (1) IS5141A (no)
MA (1) MA24485A1 (no)
NO (1) NO994178D0 (no)
NZ (1) NZ336627A (no)
OA (1) OA11088A (no)
PA (1) PA8446901A1 (no)
PE (1) PE57999A1 (no)
PL (1) PL335307A1 (no)
PT (1) PT964860E (no)
SK (1) SK113199A3 (no)
TN (1) TNSN98034A1 (no)
TR (1) TR199902094T2 (no)
TW (1) TW530055B (no)
UA (1) UA58536C2 (no)
WO (1) WO1998038187A1 (no)
ZA (1) ZA981665B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323208B1 (en) * 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
JPH11279158A (ja) * 1998-02-09 1999-10-12 Pfizer Prod Inc キナゾリン―4―オン誘導体の製造方法
US6890930B1 (en) * 1999-09-28 2005-05-10 3-Dimensional Pharmaceuticals, Inc. Quinazolinones
JP2007501809A (ja) * 2003-08-08 2007-02-01 ユリシーズ・ファーマシューティカル・プロダクツ・インコーポレイテッド 抗菌剤としてのハロゲン化キナゾリニルニトロフラン
US20080146562A1 (en) * 2003-08-08 2008-06-19 Ulysses Pharmaceutical Products Inc., Halogenated quinazolinyl nitrofurans as antibacterial agents
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
WO2007056124A2 (en) 2005-11-04 2007-05-18 Hydra Biosciences, Inc. Compounds for modulating trpv3 function
EP2079739A2 (en) * 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
WO2008140750A1 (en) * 2007-05-10 2008-11-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
PE20120602A1 (es) * 2009-03-24 2012-05-21 Gilead Calistoga Llc ATROPISOMEROS DE 2-[(6-AMINO-9H-PURIN-9-IL)METIL]-5-METIL-3-o-TOLILQUINAZOLIN-4(3H)-ONA
AU2010254149B2 (en) 2009-05-29 2014-08-21 Merck Sharp & Dohme Llc Radiolabeled PDE10 inhibitors
WO2013105985A1 (en) * 2011-02-28 2013-07-18 Philadelphia Health & Education Corporation Small molecule inhibitors of rad51 recombinase and methods thereof
JP2023512664A (ja) 2020-01-29 2023-03-28 カマリ ファーマ リミテッド 皮膚障害の治療に使用するための化合物及び組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748325A (en) 1970-04-06 1973-07-24 Karamchand Premchand Private Process for the preparation of quinazolinone derivatives
US4183931A (en) * 1977-09-08 1980-01-15 Research Corporation 2-Ketoalkyl-4(3H)-quinazolinones
WO1992013535A1 (en) * 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
TR199802296T2 (xx) 1996-05-15 1999-02-22 Pfizer Inc. Yeni 2,3 dis�bstit�te-4 (3H)-kinazolinonlar
PT807633E (pt) * 1996-05-15 2003-02-28 Pfizer Novas pirimidin-4-onas substituidas em 2,3, e fundidas com heteroarilo em (5,6)

Also Published As

Publication number Publication date
NZ336627A (en) 2000-12-22
BG103687A (en) 2000-06-30
OA11088A (en) 2002-03-15
JP3299990B2 (ja) 2002-07-08
BR9807807A (pt) 2000-02-22
IS5141A (is) 1999-07-30
EP0964860A1 (en) 1999-12-22
PT964860E (pt) 2004-07-30
HRP980108B1 (en) 2004-10-31
ZA981665B (en) 1999-08-17
KR20000075812A (ko) 2000-12-26
US6380204B1 (en) 2002-04-30
IL130897A0 (en) 2001-01-28
SK113199A3 (en) 2001-10-08
HRP980108A2 (en) 1998-12-31
DE69823339D1 (de) 2004-05-27
TW530055B (en) 2003-05-01
HUP0000935A2 (hu) 2001-04-28
EA199900689A1 (ru) 2000-02-28
EA001961B1 (ru) 2001-10-22
JP2000509732A (ja) 2000-08-02
AU5775998A (en) 1998-09-18
PA8446901A1 (es) 2000-05-24
AP9801202A0 (en) 1999-08-26
NO994178L (no) 1999-08-27
PL335307A1 (en) 2000-04-10
DZ2438A1 (fr) 2003-01-11
GT199800039A (es) 1999-08-13
UA58536C2 (uk) 2003-08-15
PE57999A1 (es) 1999-06-21
DK0964860T3 (da) 2004-07-26
HUP0000935A3 (en) 2002-04-29
AR011886A1 (es) 2000-09-13
HN1998000028A (es) 1999-02-09
AU732448B2 (en) 2001-04-26
CO4950615A1 (es) 2000-09-01
ID23435A (id) 2000-04-20
TR199902094T2 (xx) 1999-12-21
TNSN98034A1 (fr) 2005-03-15
CN1248254A (zh) 2000-03-22
EP0964860B1 (en) 2004-04-21
ES2218801T3 (es) 2004-11-16
MA24485A1 (fr) 1998-10-01
ATE264854T1 (de) 2004-05-15
CA2282279A1 (en) 1998-09-03
DE69823339T2 (de) 2005-05-12
WO1998038187A1 (en) 1998-09-03
CA2282279C (en) 2004-11-02

Similar Documents

Publication Publication Date Title
NO996483L (no) Imidasopyrimidiner og imidasopyridiner for behandling av neurologiske lidelser
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
NO970444L (no) Fremgangsmåte for fremstilling av metaller og andre elementer
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
NO994178D0 (no) Atropisomere av 3-heteroaryl-4(3H)-kinazoloner for behandling av neurodegenerative og CNS-trauma-relaterte tilstander
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
DK1165510T3 (da) 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
NO20014674L (no) Fremgangsmåte for behandling av neurologiske og neuropsykiatriske forstyrrelser
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
NO983512D0 (no) Midler for behandling og forhindring av AIDS
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
NO20003211D0 (no) Triazinforbindelser for behandling av CNS forstyrrelser
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
DK0981349T3 (da) 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme
NO20010390D0 (no) Behandling av angstsykdommer
IL126681A0 (en) Treatment of trauma-related conditions
NO953089L (no) Steroider for behandling av klimakterieplager
NO20025760L (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
DK0728706T3 (da) Fremgangsmåde og installation til behandling af fedtet affald
DK82798A (da) Treatment of GABA-uptake related disorders